TELO — Telomir Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: Telomir Pharmaceuticals Inc - Announces Telomir-1 Inhibits Epigenetic Enzymes
Brief: Telomir Pharmaceuticals Inc - Telomir-1 Significantly Increased Cell Viability - SEC Filing
Brief: Telomir Pharmaceuticals Says Positive Preclinical Results For Telomir-1 In Wilson’S Disease Animal Model
Brief: Telomir Pharmaceuticals-New Data From Preclinical Study Of Its Lead Compound, Telomir-1, In Validated Animal Model Of Werner Syndrome
Brief: Telomir Pharmaceuticals Inc - Michelle Yanez Steps Down As CFO Of Telomir Pharmaceuticals - SEC Filing
Brief: Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1
Brief: Telomir Pharmaceuticals Confirms Lifespan Restoration And Normalization Of Accelerated Aging In Preclinical Model Of Progeria